The European Patent Office intends to grant Brighter a patent for the use of a proximity sensor to log insulin injections in Actiste.
Brighter's patent for the use of a proximity sensor to log insulin injections will be granted by the European Patent Office. The proximity sensor automatically disregards any fluid released from the injector during priming, so this is not registered as an injected dose. The patent is not limited to insulin and applies to use of this function in many injection devices with any pharmaceutical, to disregard priming. It is recommended to prime the injector in order to remove air bubbles from the needle to ensure full dose administration. The sensor that registers data on the actual injected